Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UMBRALISIB vs URSODIOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

UMBRALISIB vs URSODIOL: Safety Overview

Metric UMBRALISIB URSODIOL
Total FAERS Reports 293 3,624
Deaths Reported 30 539
Death Rate 10.2% 14.9%
Hospitalizations 97 1,257
Average Patient Age 69.0 yrs 44.3 yrs
% Female Patients 43.8% 61.7%
FDA Approval Date Feb 5, 2021 Aug 14, 2024
Manufacturer N/A Zydus Pharmaceuticals (USA) Inc.
Route N/A ORAL
Marketing Status Discontinued Discontinued